日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Awareness, Attitudes, and Barriers to Breast Cancer Screening Among Breast Screening Health Education Week Attendees at King Saud Medical City, Riyadh

利雅得国王沙特医疗城乳腺癌筛查健康教育周参与者对乳腺癌筛查的认知、态度和障碍

期刊:International Journal of Breast Cancer
影响因子:3
doi:10.1155/ijbc/7289188
Alturki, Atheer; Elnasieh, AbdulRahman M; Alhadlaq, Razan; Al Saluly, Firas; Hawidi, Faisal Bin; Alzuwaidi, Ahoud S; Alaidarous, Taghreed Mohammed; Ajarim, Khalid M; Alharabi, Meshari K
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

PALB2 germline mutations in a large cohort of Middle Eastern breast-ovarian cancer patients

在中东乳腺癌-卵巢癌患者大型队列中发现PALB2种系突变

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-34693-9
Siraj, Abdul K; Bu, Rong; Parvathareddy, Sandeep Kumar; Iqbal, Kaleem; Azam, Saud; Qadri, Zeeshan; Al-Rasheed, Maha; Haqawi, Wael; Diaz, Mark; Victoria, Ingrid G; Al-Badawi, Ismail A; Tulbah, Asma; Al-Dayel, Fouad; Ajarim, Dahish; Al-Kuraya, Khawla S
肿瘤
PALB2
肿瘤免疫
乳腺癌
卵巢癌
发表日期：2023
文献求助 收藏

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia

沙特阿拉伯新诊断的非转移性乳腺癌患者的肥胖与临床病理特征之间的关联

期刊:International Journal of Womens Health
影响因子:2.6
doi:10.2147/IJWH.S343558
Alshamsan, Bader; Suleman, Kausar; Agha, Naela; Abdelgawad, Marwa I; Alzahrani, Mashari J; Elhassan, Tusneem; Al-Tweigeri, Taher; Ajarim, Dahish; Alsayed, Adher
肿瘤
肿瘤免疫
乳腺癌
代谢
肥胖
发表日期：2022
文献求助 收藏

High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer

细胞周期蛋白D1高表达是中东乳腺癌预后良好的独立标志物

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S309091
Siraj, Abdul K; Parvathareddy, Sandeep Kumar; Annaiyappanaidu, Padmanaban; Ahmed, Saeeda O; Siraj, Nabil; Tulbah, Asma; Al-Dayel, Fouad; Ajarim, Dahish; Al-Kuraya, Khawla S
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer

中性粒细胞-淋巴细胞比值与早期激素受体阳性、HER2阴性、淋巴结阴性乳腺癌Oncotype Dx复发评分的相关性

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S343549
Alshamsan, Bader; Alshibany, Aisha; Elshenawy, Mahmoud A; Badran, Ahmed; Elhassan, Tusneem; Ajarim, Dahish; Alsayed, Adher; Suleman, Kausar; Al-Tweigeri, Taher
肿瘤
中性粒细胞
HER2
肿瘤免疫
信号转导
乳腺癌
粒细胞
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients

中东早发性乳腺癌患者中生殖系TP53突变的患病率

期刊:Hereditary Cancer in Clinical Practice
影响因子:2.4
doi:10.1186/s13053-021-00206-w
Siraj, Abdul Khalid; Masoodi, Tariq; Bu, Rong; Parvathareddy, Sandeep Kumar; Iqbal, Kaleem; Azam, Saud; Al-Rasheed, Maha; Ajarim, Dahish; Tulbah, Asma; Al-Dayel, Fouad; Al-Kuraya, Khawla Sami
肿瘤
P53
乳腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

曲妥珠单抗、帕妥珠单抗和多西他赛作为阿拉伯人群中HER-2阳性转移性乳腺癌的一线治疗方案

期刊:Breast Care
影响因子:2.1
doi:10.1159/000506824
Suleman, Kausar; Mushtaq, Ali Hassan; Haque, Emaan; Badran, Ahmed Ali; Ajarim, Dahish; Elashwah, Ahmed Mohammed; Gad, Ahmed Mostafa; Abdelsamad, Amgad Shaheen; Omar, Ayman; Khan, Khurshid Ahmed; Al-Tweigeri, Taher; Elshentenawy, Ayman; Alsayed, Adher
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer

新辅助化疗±曲妥珠单抗治疗局部晚期乳腺癌后病理完全缓解的影响

期刊:Journal of Oncology
影响因子:
doi:10.1155/2021/6639763
Al-Tweigeri, Taher; Elshenawy, Mahmoud; Badran, Ahmed; Omar, Ayman; Suleman, Kausar; Al Malik, Osama; Anwar, Ihab; Jastaniya, Noha; Tulbah, Asma; Al Shabanah, Mohammad; Ajarim, Dahish; Al Sayed, Adher
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment

PARP 过度表达是中东乳腺癌生存率低的独立预后标志物，可通过 embelin 联合治疗增强其抑制作用

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.26470
Abdul Khalid Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, Sasidharan Padmaja Divya, Fouad Al-Dayel, Asma Tulbah, Dahish Ajarim, Khawla S Al-Kuraya
肿瘤
乳腺癌
发表日期：2018
文献求助 收藏

FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer

FoxM1 是中东晚期乳腺癌的独立不良预后标志物和治疗靶点

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.24739
Abdul Khalid Siraj, Poyil Pratheeshkumar, Sandeep Kumar Parvathareddy, Zeeshan Qadri, Saravanan Thangavel, Saeeda Ahmed, Fouad Al-Dayel, Asma Tulbah, Dahish Ajarim, Khawla S Al-Kuraya
肿瘤
乳腺癌
FCM
IF
IHC-P
WB
FOXM1
发表日期：2018
文献求助 收藏